Drugs / Towne
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00373412 | Oct 2006 → Feb 2008 | cytomegalovirus infection | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Towne | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00373412 ↗ |
| Modality | Vaccine | “live, attenuated Towne CMV vaccine” NCT00373412 ↗ |
| Route | Subcutaneous | “Towne vacine (3000 pfu) subcutaneously” NCT00373412 ↗ |